Evidence-based standardized Cirrhosis order set for Liver Cirrhosis

Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upbaseline, 1 year, 2 year
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test whether the CCAB improves patient outcomes.

Eligible Conditions
  • Liver Cirrhosis


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 year, 2 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 year, 2 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cumulative hospital length of stay (LOS) per patient year
Secondary outcome measures
Disease severity
Emergency Department (ED) Visit Rate
Hospital Readmission Rate
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Use of a standardized cirrhosis order set.
Group II: ControlActive Control1 Intervention
Current practice at baseline, routine cirrhosis care.
Group III: Intervention + EMRActive Control1 Intervention
Use of a standardized cirrhosis order set embedded within an electronic medical record.

Find a site

Who is running the clinical trial?

Alberta Innovates Health SolutionsOTHER
51 Previous Clinical Trials
99,738 Total Patients Enrolled
Alberta Health servicesOTHER
151 Previous Clinical Trials
329,737 Total Patients Enrolled
University of AlbertaLead Sponsor
864 Previous Clinical Trials
386,806 Total Patients Enrolled
9 Trials studying Liver Cirrhosis
1,851 Patients Enrolled for Liver Cirrhosis

Media Library

Evidence-based standardized Cirrhosis order set (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04149223 — N/A
Liver Cirrhosis Research Study Groups: Intervention, Control, Intervention + EMR
Liver Cirrhosis Clinical Trial 2023: Evidence-based standardized Cirrhosis order set Highlights & Side Effects. Trial Name: NCT04149223 — N/A
Evidence-based standardized Cirrhosis order set (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04149223 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open positions for participants at this time?

"Affirmative. Clinicaltrials.gov has the latest information which confirms that this medical research is actively seeking patients for its study, initiated on June 1st 2019 and last updated on May 19th 2022. The project needs 3975 test subjects from one location to complete their trial."

Answered by AI

How many people are participating in this medical investigation?

"Indeed, clinicaltrials.gov exhibits that this experiment is searching for subjects as of now. It was first announced on June 1st 2019 and the latest update occurred on May 19th 2022. A total of 3975 patients need to be recruited from a single medical facility."

Answered by AI
~0 spots leftby Nov 2023